img

Global Pharma Sustained Release Excipient Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pharma Sustained Release Excipient Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Pharma Sustained Release Excipient report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pharma Sustained Release Excipient market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Pharmaceutical and Health Care are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Pharma Sustained Release Excipient industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Pharma Sustained Release Excipient key manufacturers include Teva Pharmaceutical Industries, Mylan N.V., Valeant Pharmaceuticals International, Pfizer, Sun Pharmaceutical Industries, Novartis AG, AstraZeneca, GlaxoSmithKline and Allergan, etc. Teva Pharmaceutical Industries, Mylan N.V., Valeant Pharmaceuticals International are top 3 players and held % sales share in total in 2022.
Pharma Sustained Release Excipient can be divided into Gelatin, Polymers, Minerals and Sugars, etc. Gelatin is the mainstream product in the market, accounting for % sales share globally in 2022.
Pharma Sustained Release Excipient is widely used in various fields, such as Pharmaceutical, Health Care and Others,, etc. Pharmaceutical provides greatest supports to the Pharma Sustained Release Excipient industry development. In 2022, global % sales of Pharma Sustained Release Excipient went into Pharmaceutical filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pharma Sustained Release Excipient market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Teva Pharmaceutical Industries
Mylan N.V.
Valeant Pharmaceuticals International
Pfizer
Sun Pharmaceutical Industries
Novartis AG
AstraZeneca
GlaxoSmithKline
Allergan
Janssen Pharmaceuticals
Mayne Pharma Group
BASF
International Flavors & Fragrances
Ashland Global
Evonik Industries
Croda International
Gattefosse
Merck KGaA
Segment by Type
Gelatin
Polymers
Minerals
Sugars
Chitosan

Segment by Application


Pharmaceutical
Health Care
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pharma Sustained Release Excipient market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pharma Sustained Release Excipient, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pharma Sustained Release Excipient industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Pharma Sustained Release Excipient in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pharma Sustained Release Excipient introduction, etc. Pharma Sustained Release Excipient Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Pharma Sustained Release Excipient market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Pharma Sustained Release Excipient Market Overview
1.1 Pharma Sustained Release Excipient Product Overview
1.2 Pharma Sustained Release Excipient Market Segment by Type
1.2.1 Gelatin
1.2.2 Polymers
1.2.3 Minerals
1.2.4 Sugars
1.2.5 Chitosan
1.3 Global Pharma Sustained Release Excipient Market Size by Type
1.3.1 Global Pharma Sustained Release Excipient Market Size Overview by Type (2024-2034)
1.3.2 Global Pharma Sustained Release Excipient Historic Market Size Review by Type (2024-2024)
1.3.3 Global Pharma Sustained Release Excipient Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pharma Sustained Release Excipient Sales Breakdown by Type (2024-2024)
1.4.2 Europe Pharma Sustained Release Excipient Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Pharma Sustained Release Excipient Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Pharma Sustained Release Excipient Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Pharma Sustained Release Excipient Sales Breakdown by Type (2024-2024)
2 Global Pharma Sustained Release Excipient Market Competition by Company
2.1 Global Top Players by Pharma Sustained Release Excipient Sales (2024-2024)
2.2 Global Top Players by Pharma Sustained Release Excipient Revenue (2024-2024)
2.3 Global Top Players by Pharma Sustained Release Excipient Price (2024-2024)
2.4 Global Top Manufacturers Pharma Sustained Release Excipient Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pharma Sustained Release Excipient Market Competitive Situation and Trends
2.5.1 Pharma Sustained Release Excipient Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Pharma Sustained Release Excipient Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharma Sustained Release Excipient as of 2022)
2.7 Date of Key Manufacturers Enter into Pharma Sustained Release Excipient Market
2.8 Key Manufacturers Pharma Sustained Release Excipient Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pharma Sustained Release Excipient Status and Outlook by Region
3.1 Global Pharma Sustained Release Excipient Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Pharma Sustained Release Excipient Historic Market Size by Region
3.2.1 Global Pharma Sustained Release Excipient Sales in Volume by Region (2024-2024)
3.2.2 Global Pharma Sustained Release Excipient Sales in Value by Region (2024-2024)
3.2.3 Global Pharma Sustained Release Excipient Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Pharma Sustained Release Excipient Forecasted Market Size by Region
3.3.1 Global Pharma Sustained Release Excipient Sales in Volume by Region (2024-2034)
3.3.2 Global Pharma Sustained Release Excipient Sales in Value by Region (2024-2034)
3.3.3 Global Pharma Sustained Release Excipient Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Pharma Sustained Release Excipient by Application
4.1 Pharma Sustained Release Excipient Market Segment by Application
4.1.1 Pharmaceutical
4.1.2 Health Care
4.1.3 Others
4.2 Global Pharma Sustained Release Excipient Market Size by Application
4.2.1 Global Pharma Sustained Release Excipient Market Size Overview by Application (2024-2034)
4.2.2 Global Pharma Sustained Release Excipient Historic Market Size Review by Application (2024-2024)
4.2.3 Global Pharma Sustained Release Excipient Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pharma Sustained Release Excipient Sales Breakdown by Application (2024-2024)
4.3.2 Europe Pharma Sustained Release Excipient Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Pharma Sustained Release Excipient Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Pharma Sustained Release Excipient Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Pharma Sustained Release Excipient Sales Breakdown by Application (2024-2024)
5 North America Pharma Sustained Release Excipient by Country
5.1 North America Pharma Sustained Release Excipient Historic Market Size by Country
5.1.1 North America Pharma Sustained Release Excipient Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Pharma Sustained Release Excipient Sales in Volume by Country (2024-2024)
5.1.3 North America Pharma Sustained Release Excipient Sales in Value by Country (2024-2024)
5.2 North America Pharma Sustained Release Excipient Forecasted Market Size by Country
5.2.1 North America Pharma Sustained Release Excipient Sales in Volume by Country (2024-2034)
5.2.2 North America Pharma Sustained Release Excipient Sales in Value by Country (2024-2034)
6 Europe Pharma Sustained Release Excipient by Country
6.1 Europe Pharma Sustained Release Excipient Historic Market Size by Country
6.1.1 Europe Pharma Sustained Release Excipient Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Pharma Sustained Release Excipient Sales in Volume by Country (2024-2024)
6.1.3 Europe Pharma Sustained Release Excipient Sales in Value by Country (2024-2024)
6.2 Europe Pharma Sustained Release Excipient Forecasted Market Size by Country
6.2.1 Europe Pharma Sustained Release Excipient Sales in Volume by Country (2024-2034)
6.2.2 Europe Pharma Sustained Release Excipient Sales in Value by Country (2024-2034)
7 Asia-Pacific Pharma Sustained Release Excipient by Region
7.1 Asia-Pacific Pharma Sustained Release Excipient Historic Market Size by Region
7.1.1 Asia-Pacific Pharma Sustained Release Excipient Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Pharma Sustained Release Excipient Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Pharma Sustained Release Excipient Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Pharma Sustained Release Excipient Forecasted Market Size by Region
7.2.1 Asia-Pacific Pharma Sustained Release Excipient Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Pharma Sustained Release Excipient Sales in Value by Region (2024-2034)
8 Latin America Pharma Sustained Release Excipient by Country
8.1 Latin America Pharma Sustained Release Excipient Historic Market Size by Country
8.1.1 Latin America Pharma Sustained Release Excipient Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Pharma Sustained Release Excipient Sales in Volume by Country (2024-2024)
8.1.3 Latin America Pharma Sustained Release Excipient Sales in Value by Country (2024-2024)
8.2 Latin America Pharma Sustained Release Excipient Forecasted Market Size by Country
8.2.1 Latin America Pharma Sustained Release Excipient Sales in Volume by Country (2024-2034)
8.2.2 Latin America Pharma Sustained Release Excipient Sales in Value by Country (2024-2034)
9 Middle East and Africa Pharma Sustained Release Excipient by Country
9.1 Middle East and Africa Pharma Sustained Release Excipient Historic Market Size by Country
9.1.1 Middle East and Africa Pharma Sustained Release Excipient Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Pharma Sustained Release Excipient Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Pharma Sustained Release Excipient Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Pharma Sustained Release Excipient Forecasted Market Size by Country
9.2.1 Middle East and Africa Pharma Sustained Release Excipient Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Pharma Sustained Release Excipient Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Teva Pharmaceutical Industries
10.1.1 Teva Pharmaceutical Industries Company Information
10.1.2 Teva Pharmaceutical Industries Introduction and Business Overview
10.1.3 Teva Pharmaceutical Industries Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Teva Pharmaceutical Industries Pharma Sustained Release Excipient Products Offered
10.1.5 Teva Pharmaceutical Industries Recent Development
10.2 Mylan N.V.
10.2.1 Mylan N.V. Company Information
10.2.2 Mylan N.V. Introduction and Business Overview
10.2.3 Mylan N.V. Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Mylan N.V. Pharma Sustained Release Excipient Products Offered
10.2.5 Mylan N.V. Recent Development
10.3 Valeant Pharmaceuticals International
10.3.1 Valeant Pharmaceuticals International Company Information
10.3.2 Valeant Pharmaceuticals International Introduction and Business Overview
10.3.3 Valeant Pharmaceuticals International Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Valeant Pharmaceuticals International Pharma Sustained Release Excipient Products Offered
10.3.5 Valeant Pharmaceuticals International Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Pfizer Pharma Sustained Release Excipient Products Offered
10.4.5 Pfizer Recent Development
10.5 Sun Pharmaceutical Industries
10.5.1 Sun Pharmaceutical Industries Company Information
10.5.2 Sun Pharmaceutical Industries Introduction and Business Overview
10.5.3 Sun Pharmaceutical Industries Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Sun Pharmaceutical Industries Pharma Sustained Release Excipient Products Offered
10.5.5 Sun Pharmaceutical Industries Recent Development
10.6 Novartis AG
10.6.1 Novartis AG Company Information
10.6.2 Novartis AG Introduction and Business Overview
10.6.3 Novartis AG Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Novartis AG Pharma Sustained Release Excipient Products Offered
10.6.5 Novartis AG Recent Development
10.7 AstraZeneca
10.7.1 AstraZeneca Company Information
10.7.2 AstraZeneca Introduction and Business Overview
10.7.3 AstraZeneca Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2024-2024)
10.7.4 AstraZeneca Pharma Sustained Release Excipient Products Offered
10.7.5 AstraZeneca Recent Development
10.8 GlaxoSmithKline
10.8.1 GlaxoSmithKline Company Information
10.8.2 GlaxoSmithKline Introduction and Business Overview
10.8.3 GlaxoSmithKline Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2024-2024)
10.8.4 GlaxoSmithKline Pharma Sustained Release Excipient Products Offered
10.8.5 GlaxoSmithKline Recent Development
10.9 Allergan
10.9.1 Allergan Company Information
10.9.2 Allergan Introduction and Business Overview
10.9.3 Allergan Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Allergan Pharma Sustained Release Excipient Products Offered
10.9.5 Allergan Recent Development
10.10 Janssen Pharmaceuticals
10.10.1 Janssen Pharmaceuticals Company Information
10.10.2 Janssen Pharmaceuticals Introduction and Business Overview
10.10.3 Janssen Pharmaceuticals Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Janssen Pharmaceuticals Pharma Sustained Release Excipient Products Offered
10.10.5 Janssen Pharmaceuticals Recent Development
10.11 Mayne Pharma Group
10.11.1 Mayne Pharma Group Company Information
10.11.2 Mayne Pharma Group Introduction and Business Overview
10.11.3 Mayne Pharma Group Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Mayne Pharma Group Pharma Sustained Release Excipient Products Offered
10.11.5 Mayne Pharma Group Recent Development
10.12 BASF
10.12.1 BASF Company Information
10.12.2 BASF Introduction and Business Overview
10.12.3 BASF Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2024-2024)
10.12.4 BASF Pharma Sustained Release Excipient Products Offered
10.12.5 BASF Recent Development
10.13 International Flavors & Fragrances
10.13.1 International Flavors & Fragrances Company Information
10.13.2 International Flavors & Fragrances Introduction and Business Overview
10.13.3 International Flavors & Fragrances Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2024-2024)
10.13.4 International Flavors & Fragrances Pharma Sustained Release Excipient Products Offered
10.13.5 International Flavors & Fragrances Recent Development
10.14 Ashland Global
10.14.1 Ashland Global Company Information
10.14.2 Ashland Global Introduction and Business Overview
10.14.3 Ashland Global Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Ashland Global Pharma Sustained Release Excipient Products Offered
10.14.5 Ashland Global Recent Development
10.15 Evonik Industries
10.15.1 Evonik Industries Company Information
10.15.2 Evonik Industries Introduction and Business Overview
10.15.3 Evonik Industries Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Evonik Industries Pharma Sustained Release Excipient Products Offered
10.15.5 Evonik Industries Recent Development
10.16 Croda International
10.16.1 Croda International Company Information
10.16.2 Croda International Introduction and Business Overview
10.16.3 Croda International Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2024-2024)
10.16.4 Croda International Pharma Sustained Release Excipient Products Offered
10.16.5 Croda International Recent Development
10.17 Gattefosse
10.17.1 Gattefosse Company Information
10.17.2 Gattefosse Introduction and Business Overview
10.17.3 Gattefosse Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2024-2024)
10.17.4 Gattefosse Pharma Sustained Release Excipient Products Offered
10.17.5 Gattefosse Recent Development
10.18 Merck KGaA
10.18.1 Merck KGaA Company Information
10.18.2 Merck KGaA Introduction and Business Overview
10.18.3 Merck KGaA Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2024-2024)
10.18.4 Merck KGaA Pharma Sustained Release Excipient Products Offered
10.18.5 Merck KGaA Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pharma Sustained Release Excipient Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pharma Sustained Release Excipient Industrial Chain Analysis
11.4 Pharma Sustained Release Excipient Market Dynamics
11.4.1 Pharma Sustained Release Excipient Industry Trends
11.4.2 Pharma Sustained Release Excipient Market Drivers
11.4.3 Pharma Sustained Release Excipient Market Challenges
11.4.4 Pharma Sustained Release Excipient Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pharma Sustained Release Excipient Distributors
12.3 Pharma Sustained Release Excipient Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Gelatin
Table 2. Major Company of Polymers
Table 3. Major Company of Minerals
Table 4. Major Company of Sugars
Table 5. Major Company of Chitosan
Table 6. Global Pharma Sustained Release Excipient Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 7. Global Pharma Sustained Release Excipient Sales by Type (2024-2024) & (Kiloton)
Table 8. Global Pharma Sustained Release Excipient Sales Market Share in Volume by Type (2024-2024)
Table 9. Global Pharma Sustained Release Excipient Sales by Type (2024-2024) & (US& Million)
Table 10. Global Pharma Sustained Release Excipient Market Share in Value by Type (2024-2024)
Table 11. Global Pharma Sustained Release Excipient Price by Type (2024-2024) & (US$/Ton)
Table 12. Global Pharma Sustained Release Excipient Sales by Type (2024-2034) & (Kiloton)
Table 13. Global Pharma Sustained Release Excipient Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Pharma Sustained Release Excipient Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Pharma Sustained Release Excipient Sales Market Share in Value by Type (2024-2034)
Table 16. Global Pharma Sustained Release Excipient Price by Type (2024-2034) & (US$/Ton)
Table 17. North America Pharma Sustained Release Excipient Sales by Type (2024-2024) & (Kiloton)
Table 18. North America Pharma Sustained Release Excipient Sales by Type (2024-2024) & (US$ Million)
Table 19. Europe Pharma Sustained Release Excipient Sales (Kiloton) by Type (2024-2024)
Table 20. Europe Pharma Sustained Release Excipient Sales by Type (2024-2024) & (US$ Million)
Table 21. Asia-Pacific Pharma Sustained Release Excipient Sales (Kiloton) by Type (2024-2024)
Table 22. Asia-Pacific Pharma Sustained Release Excipient Sales by Type (2024-2024) & (US$ Million)
Table 23. Latin America Pharma Sustained Release Excipient Sales (Kiloton) by Type (2024-2024)
Table 24. Latin America Pharma Sustained Release Excipient Sales by Type (2024-2024) & (US$ Million)
Table 25. Middle East and Africa Pharma Sustained Release Excipient Sales (Kiloton) by Type (2024-2024)
Table 26. Middle East and Africa Pharma Sustained Release Excipient Sales by Type (2024-2024) & (US$ Million)
Table 27. Global Pharma Sustained Release Excipient Sales by Company (2024-2024) & (Kiloton)
Table 28. Global Pharma Sustained Release Excipient Sales Share by Company (2024-2024)
Table 29. Global Pharma Sustained Release Excipient Revenue by Company (2024-2024) & (US$ Million)
Table 30. Global Pharma Sustained Release Excipient Revenue Share by Company (2024-2024)
Table 31. Global Market Pharma Sustained Release Excipient Price by Company (2024-2024) & (US$/Ton)
Table 32. Global Pharma Sustained Release Excipient Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Pharma Sustained Release Excipient Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharma Sustained Release Excipient as of 2022)
Table 35. Date of Key Manufacturers Enter into Pharma Sustained Release Excipient Market
Table 36. Key Manufacturers Pharma Sustained Release Excipient Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Pharma Sustained Release Excipient Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 39. Global Pharma Sustained Release Excipient Sales by Region (2024-2024) & (Kiloton)
Table 40. Global Pharma Sustained Release Excipient Sales Market Share in Volume by Region (2024-2024)
Table 41. Global Pharma Sustained Release Excipient Sales by Region (2024-2024) & (US$ Million)
Table 42. Global Pharma Sustained Release Excipient Sales Market Share in Value by Region (2024-2024)
Table 43. Global Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2024)
Table 44. Global Pharma Sustained Release Excipient Sales by Region (2024-2034) & (Kiloton)
Table 45. Global Pharma Sustained Release Excipient Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Pharma Sustained Release Excipient Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Pharma Sustained Release Excipient Sales Market Share in Value by Region (2024-2034)
Table 48. Global Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2034)
Table 49. Global Pharma Sustained Release Excipient Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 50. Global Pharma Sustained Release Excipient Sales by Application (2024-2024) & (Kiloton)
Table 51. Global Pharma Sustained Release Excipient Sales Market Share in Volume by Application (2024-2024)
Table 52. Global Pharma Sustained Release Excipient Sales by Application (2024-2024) & (US$ Million)
Table 53. Global Pharma Sustained Release Excipient Sales Market Share in Value by Application (2024-2024)
Table 54. Global Pharma Sustained Release Excipient Price by Application (2024-2024) & (US$/Ton)
Table 55. Global Pharma Sustained Release Excipient Sales by Application (2024-2034) & (Kiloton)
Table 56. Global Pharma Sustained Release Excipient Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Pharma Sustained Release Excipient Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Pharma Sustained Release Excipient Sales Market Share in Value by Application (2024-2034)
Table 59. Global Pharma Sustained Release Excipient Price by Application (2024-2034) & (US$/Ton)
Table 60. North America Pharma Sustained Release Excipient Sales by Application (2024-2024) (Kiloton)
Table 61. North America Pharma Sustained Release Excipient Sales by Application (2024-2024) & (US$ Million)
Table 62. Europe Pharma Sustained Release Excipient Sales by Application (2024-2024) (Kiloton)
Table 63. Europe Pharma Sustained Release Excipient Sales by Application (2024-2024) & (US$ Million)
Table 64. Asia-Pacific Pharma Sustained Release Excipient Sales by Application (2024-2024) (Kiloton)
Table 65. Asia-Pacific Pharma Sustained Release Excipient Sales by Application (2024-2024) & (US$ Million)
Table 66. Latin America Pharma Sustained Release Excipient Sales by Application (2024-2024) (Kiloton)
Table 67. Latin America Pharma Sustained Release Excipient Sales by Application (2024-2024) & (US$ Million)
Table 68. Middle East and Africa Pharma Sustained Release Excipient Sales by Application (2024-2024) (Kiloton)
Table 69. Middle East and Africa Pharma Sustained Release Excipient Sales by Application (2024-2024) & (US$ Million)
Table 70. North America Pharma Sustained Release Excipient Sales by Country (2024-2024) & (Kiloton)
Table 71. North America Pharma Sustained Release Excipient Sales Market Share in Volume by Country (2024-2024)
Table 72. North America Pharma Sustained Release Excipient Sales by Country (2024-2024) & (US$ Million)
Table 73. North America Pharma Sustained Release Excipient Sales Market Share in Value by Country (2024-2024)
Table 74. North America Pharma Sustained Release Excipient Sales by Country (2024-2034) & (Kiloton)
Table 75. North America Pharma Sustained Release Excipient Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Pharma Sustained Release Excipient Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Pharma Sustained Release Excipient Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Pharma Sustained Release Excipient Sales by Country (2024-2024) & (Kiloton)
Table 79. Europe Pharma Sustained Release Excipient Sales Market Share in Volume by Country (2024-2024)
Table 80. Europe Pharma Sustained Release Excipient Sales by Country (2024-2024) & (US$ Million)
Table 81. Europe Pharma Sustained Release Excipient Sales Market Share in Value by Country (2024-2024)
Table 82. Europe Pharma Sustained Release Excipient Sales by Country (2024-2034) & (Kiloton)
Table 83. Europe Pharma Sustained Release Excipient Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Pharma Sustained Release Excipient Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Pharma Sustained Release Excipient Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Pharma Sustained Release Excipient Sales by Region (2024-2024) & (Kiloton)
Table 87. Asia-Pacific Pharma Sustained Release Excipient Sales Market Share in Volume by Region (2024-2024)
Table 88. Asia-Pacific Pharma Sustained Release Excipient Sales by Region (2024-2024) & (US$ Million)
Table 89. Asia-Pacific Pharma Sustained Release Excipient Sales Market Share in Value by Region (2024-2024)
Table 90. Asia-Pacific Pharma Sustained Release Excipient Sales by Region (2024-2034) & (Kiloton)
Table 91. Asia-Pacific Pharma Sustained Release Excipient Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Pharma Sustained Release Excipient Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Pharma Sustained Release Excipient Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Pharma Sustained Release Excipient Sales by Country (2024-2024) & (Kiloton)
Table 95. Latin America Pharma Sustained Release Excipient Sales Market Share in Volume by Country (2024-2024)
Table 96. Latin America Pharma Sustained Release Excipient Sales by Country (2024-2024) & (US$ Million)
Table 97. Latin America Pharma Sustained Release Excipient Sales Market Share in Value by Country (2024-2024)
Table 98. Latin America Pharma Sustained Release Excipient Sales by Country (2024-2034) & (Kiloton)
Table 99. Latin America Pharma Sustained Release Excipient Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Pharma Sustained Release Excipient Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Pharma Sustained Release Excipient Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Pharma Sustained Release Excipient Sales by Country (2024-2024) & (Kiloton)
Table 103. Middle East and Africa Pharma Sustained Release Excipient Sales Market Share in Volume by Country (2024-2024)
Table 104. Middle East and Africa Pharma Sustained Release Excipient Sales by Country (2024-2024) & (US$ Million)
Table 105. Middle East and Africa Pharma Sustained Release Excipient Sales Market Share in Value by Country (2024-2024)
Table 106. Middle East and Africa Pharma Sustained Release Excipient Sales by Country (2024-2034) & (Kiloton)
Table 107. Middle East and Africa Pharma Sustained Release Excipient Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Pharma Sustained Release Excipient Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Pharma Sustained Release Excipient Sales Market Share in Value by Country (2024-2034)
Table 110. Teva Pharmaceutical Industries Company Information
Table 111. Teva Pharmaceutical Industries Introduction and Business Overview
Table 112. Teva Pharmaceutical Industries Pharma Sustained Release Excipient Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 113. Teva Pharmaceutical Industries Pharma Sustained Release Excipient Product
Table 114. Teva Pharmaceutical Industries Recent Development
Table 115. Mylan N.V. Company Information
Table 116. Mylan N.V. Introduction and Business Overview
Table 117. Mylan N.V. Pharma Sustained Release Excipient Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 118. Mylan N.V. Pharma Sustained Release Excipient Product
Table 119. Mylan N.V. Recent Development
Table 120. Valeant Pharmaceuticals International Company Information
Table 121. Valeant Pharmaceuticals International Introduction and Business Overview
Table 122. Valeant Pharmaceuticals International Pharma Sustained Release Excipient Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 123. Valeant Pharmaceuticals International Pharma Sustained Release Excipient Product
Table 124. Valeant Pharmaceuticals International Recent Development
Table 125. Pfizer Company Information
Table 126. Pfizer Introduction and Business Overview
Table 127. Pfizer Pharma Sustained Release Excipient Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 128. Pfizer Pharma Sustained Release Excipient Product
Table 129. Pfizer Recent Development
Table 130. Sun Pharmaceutical Industries Company Information
Table 131. Sun Pharmaceutical Industries Introduction and Business Overview
Table 132. Sun Pharmaceutical Industries Pharma Sustained Release Excipient Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 133. Sun Pharmaceutical Industries Pharma Sustained Release Excipient Product
Table 134. Sun Pharmaceutical Industries Recent Development
Table 135. Novartis AG Company Information
Table 136. Novartis AG Introduction and Business Overview
Table 137. Novartis AG Pharma Sustained Release Excipient Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 138. Novartis AG Pharma Sustained Release Excipient Product
Table 139. Novartis AG Recent Development
Table 140. AstraZeneca Company Information
Table 141. AstraZeneca Introduction and Business Overview
Table 142. AstraZeneca Pharma Sustained Release Excipient Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 143. AstraZeneca Pharma Sustained Release Excipient Product
Table 144. AstraZeneca Recent Development
Table 145. GlaxoSmithKline Company Information
Table 146. GlaxoSmithKline Introduction and Business Overview
Table 147. GlaxoSmithKline Pharma Sustained Release Excipient Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 148. GlaxoSmithKline Pharma Sustained Release Excipient Product
Table 149. GlaxoSmithKline Recent Development
Table 150. Allergan Company Information
Table 151. Allergan Introduction and Business Overview
Table 152. Allergan Pharma Sustained Release Excipient Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 153. Allergan Pharma Sustained Release Excipient Product
Table 154. Allergan Recent Development
Table 155. Janssen Pharmaceuticals Company Information
Table 156. Janssen Pharmaceuticals Introduction and Business Overview
Table 157. Janssen Pharmaceuticals Pharma Sustained Release Excipient Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 158. Janssen Pharmaceuticals Pharma Sustained Release Excipient Product
Table 159. Janssen Pharmaceuticals Recent Development
Table 160. Mayne Pharma Group Company Information
Table 161. Mayne Pharma Group Introduction and Business Overview
Table 162. Mayne Pharma Group Pharma Sustained Release Excipient Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 163. Mayne Pharma Group Pharma Sustained Release Excipient Product
Table 164. Mayne Pharma Group Recent Development
Table 165. BASF Company Information
Table 166. BASF Introduction and Business Overview
Table 167. BASF Pharma Sustained Release Excipient Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 168. BASF Pharma Sustained Release Excipient Product
Table 169. BASF Recent Development
Table 170. International Flavors & Fragrances Company Information
Table 171. International Flavors & Fragrances Introduction and Business Overview
Table 172. International Flavors & Fragrances Pharma Sustained Release Excipient Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 173. International Flavors & Fragrances Pharma Sustained Release Excipient Product
Table 174. International Flavors & Fragrances Recent Development
Table 175. Ashland Global Company Information
Table 176. Ashland Global Introduction and Business Overview
Table 177. Ashland Global Pharma Sustained Release Excipient Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 178. Ashland Global Pharma Sustained Release Excipient Product
Table 179. Ashland Global Recent Development
Table 180. Evonik Industries Company Information
Table 181. Evonik Industries Introduction and Business Overview
Table 182. Evonik Industries Pharma Sustained Release Excipient Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 183. Evonik Industries Pharma Sustained Release Excipient Product
Table 184. Evonik Industries Recent Development
Table 185. Croda International Company Information
Table 186. Croda International Introduction and Business Overview
Table 187. Croda International Pharma Sustained Release Excipient Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 188. Croda International Pharma Sustained Release Excipient Product
Table 189. Croda International Recent Development
Table 190. Gattefosse Company Information
Table 191. Gattefosse Introduction and Business Overview
Table 192. Gattefosse Pharma Sustained Release Excipient Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 193. Gattefosse Pharma Sustained Release Excipient Product
Table 194. Gattefosse Recent Development
Table 195. Merck KGaA Company Information
Table 196. Merck KGaA Introduction and Business Overview
Table 197. Merck KGaA Pharma Sustained Release Excipient Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 198. Merck KGaA Pharma Sustained Release Excipient Product
Table 199. Merck KGaA Recent Development
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Pharma Sustained Release Excipient Market Trends
Table 203. Pharma Sustained Release Excipient Market Drivers
Table 204. Pharma Sustained Release Excipient Market Challenges
Table 205. Pharma Sustained Release Excipient Market Restraints
Table 206. Pharma Sustained Release Excipient Distributors List
Table 207. Pharma Sustained Release Excipient Downstream Customers
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharma Sustained Release Excipient Product Picture
Figure 2. Global Pharma Sustained Release Excipient Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Pharma Sustained Release Excipient Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Pharma Sustained Release Excipient Sales Status and Outlook (2024-2034) & (Kiloton)
Figure 5. Product Picture of Gelatin
Figure 6. Global Gelatin Sales YoY Growth (2024-2034) & (Kiloton)
Figure 7. Product Picture of Polymers
Figure 8. Global Polymers Sales YoY Growth (2024-2034) & (Kiloton)
Figure 9. Product Picture of Minerals
Figure 10. Global Minerals Sales YoY Growth (2024-2034) & (Kiloton)
Figure 11. Product Picture of Sugars
Figure 12. Global Sugars Sales YoY Growth (2024-2034) & (Kiloton)
Figure 13. Product Picture of Chitosan
Figure 14. Global Chitosan Sales YoY Growth (2024-2034) & (Kiloton)
Figure 15. Global Pharma Sustained Release Excipient Sales by Type (2024-2034) & (US$ Million)
Figure 16. Global Pharma Sustained Release Excipient Sales Market Share by Type in 2022 & 2034
Figure 17. North America Pharma Sustained Release Excipient Sales Market Share in Volume by Type in 2022
Figure 18. North America Pharma Sustained Release Excipient Sales Market Share in Value by Type in 2022
Figure 19. Europe Pharma Sustained Release Excipient Sales Market Share in Volume by Type in 2022
Figure 20. Europe Pharma Sustained Release Excipient Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Pharma Sustained Release Excipient Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Pharma Sustained Release Excipient Sales Market Share in Value by Type in 2022
Figure 23. Latin America Pharma Sustained Release Excipient Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Pharma Sustained Release Excipient Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Pharma Sustained Release Excipient Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Pharma Sustained Release Excipient Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Pharma Sustained Release Excipient Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Pharma Sustained Release Excipient Revenue in 2022
Figure 29. Pharma Sustained Release Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 30. Product Picture of Pharmaceutical
Figure 31. Global Pharmaceutical Sales YoY Growth (2024-2034) & (Kiloton)
Figure 32. Product Picture of Health Care
Figure 33. Global Health Care Sales YoY Growth (2024-2034) & (Kiloton)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2024-2034) & (Kiloton)
Figure 36. Global Pharma Sustained Release Excipient Sales by Application (2024-2034) & (US$ Million)
Figure 37. Global Pharma Sustained Release Excipient Sales Market Share by Application in 2022 & 2034
Figure 38. North America Pharma Sustained Release Excipient Sales Market Share in Volume by Application in 2022
Figure 39. North America Pharma Sustained Release Excipient Sales Market Share in Value by Application in 2022
Figure 40. Europe Pharma Sustained Release Excipient Sales Market Share in Volume by Application in 2022
Figure 41. Europe Pharma Sustained Release Excipient Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Pharma Sustained Release Excipient Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Pharma Sustained Release Excipient Sales Market Share in Value by Application in 2022
Figure 44. Latin America Pharma Sustained Release Excipient Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Pharma Sustained Release Excipient Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Pharma Sustained Release Excipient Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Pharma Sustained Release Excipient Manufacturing Cost Structure
Figure 49. Pharma Sustained Release Excipient Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries